COVID-19 Outcome Prediction Algorithm
Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Jul 20, 2022
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on creating a test that can predict the outcomes for patients hospitalized with COVID-19. The goal is to understand both the short-term and long-term effects of the virus on people, especially those who might be at a higher risk for serious health problems. Researchers will gather information from different groups of patients, including those in large cities and military veterans, to ensure the test reflects a wide range of experiences and backgrounds.
To participate in this study, you need to be at least 18 years old and currently hospitalized with symptoms of COVID-19. If you join, you will be part of a group that helps researchers collect important data about how COVID-19 affects patients' health over time. It's important to know that only those who are experiencing symptoms of COVID-19 and have been admitted to the hospital can take part. This trial is currently looking for volunteers, and your contribution could help improve care for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Symptomatic COVID-19 infection with hospital admission
- • Age 18 and above
- • Informed consent
- Exclusion Criteria:
- • Absence of symptomatic COVID-19 infection with hospital admission
- • Age 17 or below
- • No informed consent
About University Of California, Los Angeles
The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bronx, New York, United States
Los Angeles, California, United States
Decatur, Georgia, United States
Houston, Texas, United States
Los Angeles, California, United States
Torrance, California, United States
Sylmar, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials